Financials DRTECH Corporation

Equities

A214680

KR7214680001

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
4,265 KRW +1.55% Intraday chart for DRTECH Corporation +12.83% +0.12%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 57,030 87,666 73,531 99,093 80,357 308,937
Enterprise Value (EV) 1 64,645 97,148 97,086 121,176 97,493 342,257
P/E ratio 51.6 x 101 x -10.1 x 31.3 x 14.5 x -125 x
Yield - - - - - -
Capitalization / Revenue 1.28 x 1.83 x 1.33 x 1.41 x 0.9 x 3.34 x
EV / Revenue 1.45 x 2.03 x 1.76 x 1.72 x 1.09 x 3.7 x
EV / EBITDA 20 x 21.2 x -98.1 x 19.1 x 7.42 x 43.7 x
EV / FCF -34.8 x 313 x -23.8 x -14.7 x -46 x -13 x
FCF Yield -2.87% 0.32% -4.21% -6.79% -2.17% -7.68%
Price to Book 1.82 x 2.35 x 2.22 x 2.25 x 1.34 x 3.47 x
Nbr of stocks (in thousands) 44,209 48,976 51,782 56,624 58,020 72,520
Reference price 2 1,290 1,790 1,420 1,750 1,385 4,260
Announcement Date 19/03/19 20/03/20 23/03/21 22/03/22 22/03/23 19/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 44,714 47,845 55,268 70,277 89,481 92,439
EBITDA 1 3,237 4,586 -990.1 6,335 13,143 7,830
EBIT 1 1,572 1,398 -5,490 759 6,639 -148.8
Operating Margin 3.52% 2.92% -9.93% 1.08% 7.42% -0.16%
Earnings before Tax (EBT) 1 1,380 1,140 -6,869 2,903 5,227 -852
Net income 1 1,246 944.6 -7,230 4,038 5,972 -2,248
Net margin 2.79% 1.97% -13.08% 5.75% 6.67% -2.43%
EPS 2 25.00 17.64 -141.0 55.97 95.64 -34.00
Free Cash Flow 1 -1,855 310.6 -4,087 -8,226 -2,118 -26,288
FCF margin -4.15% 0.65% -7.4% -11.7% -2.37% -28.44%
FCF Conversion (EBITDA) - 6.77% - - - -
FCF Conversion (Net income) - 32.88% - - - -
Dividend per Share - - - - - -
Announcement Date 19/03/19 20/03/20 23/03/21 22/03/22 22/03/23 19/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 7,615 9,481 23,555 22,083 17,136 33,320
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.353 x 2.067 x -23.79 x 3.486 x 1.304 x 4.255 x
Free Cash Flow 1 -1,855 311 -4,087 -8,226 -2,118 -26,288
ROE (net income / shareholders' equity) 4.31% 2.75% -22.3% 10.2% 11.4% -2.86%
ROA (Net income/ Total Assets) 2.11% 1.45% -4.22% 0.51% 3.87% -0.07%
Assets 1 59,155 65,267 171,482 790,534 154,484 3,443,241
Book Value Per Share 2 709.0 763.0 639.0 779.0 1,032 1,227
Cash Flow per Share 2 40.60 278.0 302.0 189.0 239.0 178.0
Capex 1 2,939 3,176 6,394 4,486 7,130 9,457
Capex / Sales 6.57% 6.64% 11.57% 6.38% 7.97% 10.23%
Announcement Date 19/03/19 20/03/20 23/03/21 22/03/22 22/03/23 19/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A214680 Stock
  4. Financials DRTECH Corporation